Edgewise Therapeutics completes Phase 1 trials for muscular dystrophy drug October 28, 2021 9:10:19 pm
Edgewise IPO, Inscripta round leads Colorado bioscience’s largest venture funding quarter on record April 20, 2021 8:34:02 pm
Boulder’s Edgewise Therapeutics reveals $176M IPO plan after confidential filing March 26, 2021 4:10:33 pm
